Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 15, 2000

View Archived Issues

Oxford Glyco Intends To Raise $215M As It Gains Nasdaq Listing

MediGene Filling Pipeline With U.S.-Based NeuroVir Acquisition

ReNeuron Raises #19.5M In IPO To Fund Stem Cell Technologies

Japan Tobacco Opening London Office To Increase EU Partnering

Wellcome Trust Increasing Spending To #600M Per Year

Lion, Celera Strengthen Their Collaboration In Bioinformatics

French Officials Still Not Ready To Adopt EU Biotech Directive

Merged German Firm Cardion Gains Strong Stem Cell Position

Other News To Note

GenOdyssee, UroGhne Enter Deal On Prostate Cancer SNPs

Parliament, Ministers Find Some Consensus On Directive Update

EU Commissioners Express Support For Biotech Direction

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...